Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS-24 and SINUS-52 trials

Claus Bachert, Jonathan Corren, Stella E. Lee, Haixin Zhang, Sivan Harel, Danen Cunoosamy, Asif H. Khan, Juby A. Jacob-Nara, Shahid Siddiqui, Scott Nash, Paul J. Rowe, Yamo Deniz

Research output: Contribution to journalArticlepeer-review

1 Scopus citations
Original languageEnglish
JournalInternational Forum of Allergy and Rhinology
DOIs
StateAccepted/In press - 2022
Externally publishedYes

Fingerprint

Dive into the research topics of 'Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS-24 and SINUS-52 trials'. Together they form a unique fingerprint.

Cite this